Novakand Pharma AB (publ) (STO:NOVKAN)
0.1090
-0.0102 (-8.56%)
Mar 4, 2026, 5:09 PM CET
-90.25% (1Y)
| Market Cap | 14.45M -88.3% |
| Revenue (ttm) | n/a |
| Net Income | -47.23M |
| EPS | -0.39 |
| Shares Out | 121.19M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,006,046 |
| Average Volume | 753,145 |
| Open | 0.1360 |
| Previous Close | 0.1192 |
| Day's Range | 0.0920 - 0.1360 |
| 52-Week Range | 0.0752 - 2.2500 |
| Beta | 1.02 |
| RSI | 46.29 |
| Earnings Date | Feb 20, 2026 |